-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS: NMPA APPROVAL TRIGGERS $10 MLN MILESTONE PAYMENT TO BE PAID BY SANOFI TO ARROWHEAD SUBSIDIARY VISIRNA THERAPEUTICS

Reuters·01/07/2026 12:30:01

Please log in to view news